Clinical trial
A Multicenter, Non-Interventional, Postmarketing Surveillance Study of Nusinersen Sodium Injection When Used in Routine Medical Practice in China
NCT04419233 is registered in ClinicalTrials.gov with Biogen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Non-Interventional, Postmarketing Surveillance Study of Nusinersen Sodium Injection When Used in Routine Medical Practice in China
- Lead sponsor
- Biogen
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 18, 2020
- Completion date
- November 21, 2023
- Enrollment
- 50 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.